Research Paper Volume 10, Issue 9 pp 2356—2366

A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer

Figure 4. Kaplan-Meier estimates of the overall survival of patients carrying wild-type KRAS or EGFR genes. (A) Kaplan-Meier survival curves were plotted to estimate the overall survival for patients carrying wild-type KRAS gene in two validation groups. (B) Kaplan-Meier survival curves were plotted to estimate the overall survival for patients carrying wild-type EGFR gene in two validation groups.